Found 8 matching trials
Safety and Pharmacokinetics of Alpha-1 MP (Alpha1-proteinase Inhibitor (Human), Modified Process) in Participants With Alpha1-Antitrypsin Deficiency PHASE1 This study is a multicenter, open-label trial to evaluate the safety and ph...
Show More Location
Hokkaido University Hospital
Learn More & Join Trial
Long-term Safety of Alpha1-Proteinase Inhibitor (Human) in Japanese Subjects With Alpha1 Antitrypsin Deficiency (GTI1401-OLE) PHASE1 This is a multi-center, open-label study to evaluate the long-term safety o...
Show More Location
Hiroskai University Hospital
Learn More & Join Trial
The Safety and Tolerability of Alpha-1 Modified Process (MP) In Subjects With Alpha-1-antitrypsin (AAT) Deficiency PHASE3 The purpose of this clinical study is to assess the safety and tolerability...
Show More Location
National Jewish Medical and Research Center
Learn More & Join Trial
Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD) PHASE3 This is a multi-center, randomized, placebo-controlled, double blind clinic...
Show More Status
Active Not Recruiting
Location
Grifols Investigative Site
Learn More & Join Trial
Comparison of Pharmacokinetic, Safety, Tolerability of Alpha-1 MP and Prolastin In Alpha1-antitrypsin Deficient Adults PHASE3 The purpose of this clinical study (ChAMP - Comparability pharmacokinetics ...
Show More Location
National Jewish Medical and Research Center
Learn More & Join Trial
Safety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects With Alpha1-Antitrypsin Deficiency PHASE2 This is a study to assess the safety and pharmacokinetics of weekly infusio...
Show More Location
University of Florida College of Medicine
Learn More & Join Trial
Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency PHASE3 This is a 2-year open-label, multicenter extension of the double-blind, pla...
Show More Status
Enrolling By Invitation
Location
Grifols Investigative Site
Learn More & Join Trial
Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus PHASE2 This is a multicenter, randomized, partial-blinded, five-arm, placebo-contr...
Show More Location
University of Arizona
Learn More & Join Trial